1 | 9056009 | Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. | Antimicrob Agents Chemother | 1997 Mar |
2 |
2 | 9211082 | Nelfinavir. | Drugs | 1997 Jul |
1 |
3 | 9617598 | Amprenavir. | Drugs | 1998 Jun |
1 |
4 | 9649346 | Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions. | J Pharm Sci | 1998 Jul |
1 |
5 | 9660842 | Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate. | Drug Metab Dispos | 1998 Jul |
11 |
6 | 9803961 | Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells. | J Acquir Immune Defic Syndr Hum Retrovirol | 1998 Nov 1 |
2 |
7 | 9835508 | Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters. | Antimicrob Agents Chemother | 1998 Dec |
2 |
8 | 9878993 | Efavirenz. | Drugs | 1998 Dec |
1 |
9 | 10049256 | Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells. | Antimicrob Agents Chemother | 1999 Mar |
1 |
10 | 10066640 | Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy. | Eur J Med Res | 1999 Feb 25 |
1 |
11 | 10381636 | Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. | Cell Death Differ | 1999 May |
1 |
12 | 10452644 | Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate. | Clin Infect Dis | 1999 May |
1 |
13 | 10509562 | Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. | AIDS | 1999 Sep 10 |
4 |
14 | 10597780 | Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients. | AIDS | 1999 Dec 3 |
1 |
15 | 10651392 | Didanosine: an updated review of its use in HIV infection. | Drugs | 1999 Dec |
1 |
16 | 10776836 | Nelfinavir: an update on its use in HIV infection. | Drugs | 2000 Mar |
1 |
17 | 10820137 | Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. | Drug Metab Dispos | 2000 Jun |
1 |
18 | 10926350 | Drug interactions with cisapride: clinical implications. | Clin Pharmacokinet | 2000 Jul |
1 |
19 | 10939550 | Variability in activity of hepatic CYP3A4 in patients infected with HIV. | Pharmacotherapy | 2000 Aug |
1 |
20 | 10954886 | Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team. | AIDS Res Hum Retroviruses | 2000 Aug 10 |
2 |
21 | 10996400 | HIV protease inhibitors block adipogenesis and increase lipolysis in vitro. | Antiviral Res | 2000 Aug |
2 |
22 | 11116063 | HIV protease inhibitors stimulate hepatic triglyceride synthesis. | Arterioscler Thromb Vasc Biol | 2000 Dec |
1 |
23 | 11120614 | Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection. | J Infect | 2000 Nov |
1 |
24 | 11159797 | Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. | Drug Metab Dispos | 2001 Feb |
2 |
25 | 11185676 | A study of the pharmacokinetics of azithromycin and nelfinavir when coadministered in healthy volunteers. | J Clin Pharmacol | 2000 Dec |
1 |
26 | 11302944 | Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitors. | Drug Metab Dispos | 2001 May |
2 |
27 | 11375344 | The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes. | Diabetes | 2001 Jun |
3 |
28 | 11399981 | Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients. | AIDS | 2001 May 25 |
1 |
29 | 11468419 | HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART. | J Acquir Immune Defic Syndr | 2001 Aug 1 |
1 |
30 | 11477322 | Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability. | Ther Drug Monit | 2001 Aug |
1 |
31 | 11590524 | Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposure. | HIV Clin Trials | 2001 Mar-Apr |
2 |
32 | 12176683 | Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection. | Eur J Med Res | 2002 Jul 24 |
1 |
33 | 12189360 | Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir. | Clin Pharmacol Ther | 2002 Aug |
1 |
34 | 12403023 | A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients. | West Afr J Med | 2002 Apr-Jun |
1 |
35 | 12405866 | Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection. | Clin Pharmacokinet | 2002 |
1 |
36 | 12435624 | Limited effect of food composition on the pharmacokinetics of nelfinavir administered twice daily. | Eur J Med Res | 2002 Oct 29 |
1 |
37 | 12477837 | Isolation and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replication. | J Virol | 2003 Jan |
1 |
38 | 12478066 | Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors. | AIDS | 2003 Jan 3 |
5 |
39 | 12545146 | Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy. | Clin Pharmacol Ther | 2003 Jan |
8 |
40 | 12689411 | Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion. | AIDS Res Hum Retroviruses | 2003 Mar |
1 |
41 | 12705974 | Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry. | J Chromatogr B Analyt Technol Biomed Life Sci | 2003 May 25 |
1 |
42 | 12837856 | Modulation of the LDL receptor and LRP levels by HIV protease inhibitors. | J Lipid Res | 2003 Oct |
9 |
43 | 12902797 | The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro. | J Acquir Immune Defic Syndr | 2003 Aug 15 |
4 |
44 | 12917239 | Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression. | J Antimicrob Chemother | 2003 Sep |
2 |
45 | 12949316 | Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377. | Pediatrics | 2003 Sep |
1 |
46 | 12949438 | Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology. | Digestion | 2003 |
1 |
47 | 14592951 | Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice. | Endocrinology | 2004 Feb |
1 |
48 | 15002082 | A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102). | HIV Clin Trials | 2004 Jan-Feb |
2 |
49 | 15007102 | HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). | J Pharmacol Exp Ther | 2004 Jul |
1 |
50 | 15040543 | Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV-infected patients. | Antivir Ther | 2004 Feb |
6 |